Compounds of Formula (I) and (II) are described herein, as well as their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors (in particular, the CB-1 receptor) in animals.
本文描述了式(I)和(II)的化合物,以及它们在治疗与动物体内
大麻素受体介导有关的疾病中的用途(特别是CB-1受体)。